-
Topics
-
Excellence Forums
-
Conference Coverage
-
Resources
-
Microsites
-
Events
-
Education
-
About
Advertisement
Advertisement
Advertisement
ADVERTISEMENT
Leslie Citrome, MD, MPH, and Charles Raison, MD, discuss the need for more choices in available antipsychotics and the potential for a new generation of antipsychotics with a more favorable metabolic profile.
Advertisement
Advertisement
Advertisement
Advertisement